Effects of early or late prenatal immune activation in mice on behavioral and neuroanatomical abnormalities relevant to schizophrenia in the adulthood

International Journal of Developmental Neuroscience

Volumn 58, Issue , 2017, Pages 1-8

  da Silveira, Vivian T ^a   Medeiros, Daniel de Castro ^a   Ropke, Jivago ^a   Guidine, Patricia A ^a   Rezende, Gustavo H ^a   Moraes, Marcio Flavio D ^a   Mendes, Eduardo Mazoni A M ^a   Macedo, Danielle ^b   Moreira, Fabricio A ^a   de Oliveira, Antonio Carlos P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Magnetic resonance imaging; Neurodevelopment; Poly I:C; Prenatal immune activation; Schizophrenia

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANXIETY DISORDER; ARTICLE; BRAIN LATERAL VENTRICLE; BRAIN SIZE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; IMMUNOLOGICAL PARAMETERS; LIMIT OF QUANTITATION; MALE; MORPHOMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRENATAL IMMUNE ACTIVATION; PRENATAL PERIOD; PROGENY; SCHIZOPHRENIA; SECOND TRIMESTER PREGNANCY; AGE; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; C57BL MOUSE; COMPLICATION; DIAGNOSTIC IMAGING; DISEASE MODEL; EMBRYOLOGY; FOOD PREFERENCE; GROWTH, DEVELOPMENT AND AGING; LOCOMOTION; MAMMALIAN EMBRYO; MENTAL DISORDERS; MOUSE; NEWBORN; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE;

INTERFERON INDUCING AGENT; KETAMINE; POLYINOSINIC POLYCYTIDYLIC ACID; SUCROSE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; FEMALE; FOOD PREFERENCES; INTERFERON INDUCERS; KETAMINE; LOCOMOTION; MAGNETIC RESONANCE IMAGING; MENTAL DISORDERS; MICE; MICE, INBRED C57BL; POLY I-C; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SCHIZOPHRENIA; SUCROSE;

EID: 85012237605     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2017.01.009     Document Type: Article

References (70)

1. Achim, A.M., et al. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr. Bull. 37:July (4) (2011), 811–821 (ISSN 1745-1701. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/19959704>).
2. American Psychiatric ASSOCIATION (APA), Diagnostic and Statistical Manual of Mental Disorders − DSM-5. 5th ed., 2013, APA, Washington.
3. Arnone, D., et al. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br. J. Psychiatry 195:September (3) (2009), 194–201 (ISSN 1472-1465. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/19721106>).
4. Arsenault, D., et al. The different effects of LPS and poly I:C prenatal immune challenges on the behavior, development and inflammatory responses in pregnant mice and their offspring. Brain Behav. Immun. 38:May (2014), 77–90 (ISSN 1090–2139. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/24384468>).
5. Avramopoulos, D., et al. Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation. PLoS One, 10(3), 2015, e0116696 (ISSN 1932–6203. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/25781172>).
6. Bale, T.L., Epigenetic and transgenerational reprogramming of brain development. Nat. Rev. Neurosci. 16:June (6) (2015), 332–344 (ISSN 1471-0048. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/25921815>).
7. Bitanihirwe, B.K., et al. Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 35:November (12) (2010), 2462–2478 (ISSN 1740-634X. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/20736993>).
8. Cahn, W., et al. Psychosis and brain volume changes during the first five years of schizophrenia. Eur. Neuropsychopharmacol. 19:February (2) (2009), 147–151 (ISSN 1873–7862. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/19056248>).
9. Canetta, S., et al. Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons. Mol. Psychiatry 21:July (7) (2016), 956–968 (ISSN 1476–5578. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/26830140>).
10. Chiapponi, C., et al. Age-related brain trajectories in schizophrenia: a systematic review of structural MRI studies. Psychiatry Res. 214:November (2) (2013), 83–93 (ISSN 1872–7123. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/23972726>).
11. Eyles, D., Feldon, J., Meyer, U., Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models. Transl Psychiatry, 2(February), 2012, e81 (ISSN 2158–3188. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/22832818>).
12. Faludi, G., Mirnics, K., Synaptic changes in the brain of subjects with schizophrenia. Int. J. Dev. Neurosci. 29:May (3) (2011), 305–309 (ISSN 1873-474X. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/21382468>).
13. Fatemi, S.H., et al. The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring. Neuropharmacology 62:March (3) (2012), 1290–1298 (ISSN 1873–7064. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/21277874>).
14. Forrest, C.M., et al. Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring. Mol Brain, 5, 2012, 22 (ISSN 1756–6606. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/22681877>).
15. Gao, L., et al. Association of interleukin-10 polymorphisms with schizophrenia: a meta-analysis. PLoS One, 9(3), 2014, e90407 (ISSN 1932–6203. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/24603720>).
16. Gogtay, N., et al. Three-dimensional brain growth abnormalities in childhood-onset schizophrenia visualized by using tensor-based morphometry. Proc. Natl. Acad. Sci. U. S. A. 105:October (3) (2008), 15979–15984 (ISSN 1091–6490. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/18852461>).
17. Gomides, L.F., et al. Murine model to study brain, behavior and immunity during hepatic encephalopathy. World J. Hepatol. 6:April (4) (2014), 243–250 (ISSN 1948–5182. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/24799993>).
18. Grace, A.A., Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat. Rev. Neurosci. 17:August (8) (2016), 524–532 (ISSN 1471-0048. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/27256556>).
19. Haijma, S.V., et al. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr. Bull. 39:September (5) (2013), 1129–1138 (ISSN 1745-1701. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/23042112>).
20. Howes, O., Mccutcheon, R., Stone, J., Glutamate and dopamine in schizophrenia: an update for the 21st century. J. Psychopharmacol. 29:February (2) (2015), 97–115 (ISSN 1461–7285. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/25586400>).
21. Hsiao, E.Y., Patterson, P.H., Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav. Immun. 25:May (4) (2011), 604–615 (ISSN 1090–2139. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/21195166>).
22. Ibi, D., et al. PolyI:C-induced neurodevelopmental animal model for schizophrenia. Nihon Shinkei Seishin Yakurigaku Zasshi, 31(November (5–6)), 2011 (ISSN 1340–2544. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/22256608>).
23. Juckel, G., et al. Microglial activation in a neuroinflammational animal model of schizophrenia–a pilot study. Schizophr. Res. 131:September (1–3) (2011), 96–100 (ISSN 1573–2509. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/21752601>).
24. Khandaker, G.M., et al. Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr. Res. 139:August (1–3) (2012), 161–168 (ISSN 1573–2509. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/22704639>).
25. Khandaker, G.M., et al. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol. Med. 43:February (2) (2013), 239–257 (ISSN 1469–8978. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/22717193>).
26. Lawrie, S.M., et al. Qualitative cerebral morphology in schizophrenia: a magnetic resonance imaging study and systematic literature review. Schizophr. Res. 25:May (2) (1997), 155–166 (ISSN 0920-9964. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/9187015>).
27. Lazar, N.L., Neufeld, R.W., Cain, D.P., Contribution of nonprimate animal models in understanding the etiology of schizophrenia. J. Psychiatry Neurosci. 36:July (4) (2011), E5–E29 (ISSN 1488–2434. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/21247514>).
28. Levman, J., Takahashi, E., Multivariate analyses applied to fetal, neonatal and pediatric MRI of neurodevelopmental disorders. Neuroimage Clin. 9 (2015), 532–544 (ISSN 2213-1582. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/26640765>).
29. Li, Q., et al. Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS One, 4(7), 2009 (ISSN 1932–6203. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/19629183>).
30. Li, Q., et al. Voxel-based analysis of postnatal white matter microstructure in mice exposed to immune challenge in early or late pregnancy. Neuroimage, 52(August (1)), 2010 (ISSN 1095–9572. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/20399275>).
31. Li, W.Y., Chang, Y.C., Lee, L.J., Prenatal infection affects the neuronal architecture and cognitive function in adult mice. Dev. Neurosci. 36:5 (2014), 359–370 (ISSN 1421–9859. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/24942872>).
32. Macêdo, D.S., et al. Animal models of prenatal immune challenge and their contribution to the study of schizophrenia: a systematic review. Braz. J. Med. Biol. Res. 45:March (3) (2012), 179–186 (ISSN 1414-431X. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/22392187>).
33. 1H-MRS studies. Schizophr. Bull., 39(January (1)), 2013 (ISSN 1745-1701. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/21746807>).
34. Meehan, C., et al. Effects of immune activation during early or late gestation on schizophrenia-related behaviour in adult rat offspring. Brain Behav. Immun., 2016 (ISSN 1090–2139. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/27423491>) [Epub ahead of print].
35. Meyer, U., Feldon, J., Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology (Berl.) 206:November (4) (2009), 587–602 (ISSN 1432–2072. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/19277608>).
36. Meyer, U., Feldon, J., To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 62:March (3) (2012), 1308–1321 (ISSN 1873–7064. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/21238465>).
37. Meyer, U., et al. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 29:6 (2005), 913–947 (ISSN 0149-7634. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/15964075>).
38. Meyer, U., et al. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav. Immun. 22:May (4) (2008), 469–486 (ISSN 1090–2139. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/18023140>).
39. Meyer, U., et al. Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology (Berl.) 208:March (4) (2010), 531–543 (ISSN 1432–2072. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/20041229>).
40. Meyer, U., Prenatal poly(I:C) exposure and other developmental immune activation models in rodent systems. Biol. Psychiatry 75:February (4) (2014), 307–315 (ISSN 1873–2402. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/23938317>).
41. Miller, B.J., et al. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry, 70(October (7)), 2011 (ISSN 1873–2402. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/21641581>).
42. Missault, S., et al. The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model. Brain Behav. Immun. 42:November (2014), 138–146 (ISSN 1090–2139. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/24973728>).
43. Olabi, B., et al. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol. Psychiatry 70:July (1) (2011), 88–96 (ISSN 1873–2402. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/21457946>).
44. Ozawa, K., et al. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol. Psychiatry 59:March (6) (2006), 546–554 (ISSN 0006-3223. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/16256957>).
45. Piontkewitz, Y., Assaf, Y., Weiner, I., Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. Biol. Psychiatry 66:December (11) (2009), 1038–1046 (ISSN 1873–2402. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/19726031>).
46. Piontkewitz, Y., Arad, M., Weiner, I., Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. Schizophr. Bull. 37:November (6) (2011), 1257–1269 (ISSN 1745-1701. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/20439320>).
47. Piontkewitz, Y., et al. Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats. Brain Behav. Immun. 26:February (2) (2012), 353–363 (ISSN 1090–2139. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/22154704>).
48. Piontkewitz, Y., Arad, M., Weiner, I., Tracing the development of psychosis and its prevention: what can be learned from animal models. Neuropharmacology 62:March (3) (2012), 1273–1289 (ISSN 1873–7064. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/21703648>).
49. Pircher, J., et al. Hepatitis C virus induced endothelial inflammatory response depends on the functional expression of TNFα receptor subtype 2. PLoS One, 9(11), 2014, e113351 (ISSN 1932–6203. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/25419735>).
50. Ratnayake, U., et al. Prenatal exposure to the viral mimetic poly I:C alters fetal brain cytokine expression and postnatal behaviour. Dev. Neurosci. 36:2 (2014), 83–94 (ISSN 1421–9859. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/24863806>).
51. Ribeiro, B.M., et al. Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine. Schizophr. Res. 151:December (1–3) (2013), 12–19 (ISSN 1573–2509. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/24257517>).
52. Richtand, N.M., et al. Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation. J. Psychiatr. Res. 45:September (9) (2011), 1194–1201 (ISSN 1879-1379. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/21440257>).
53. Roenker, N.L., et al. Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801. Neurosci. Lett. 500:August (3) (2011), 167–171 (ISSN 1872–7972. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/21699956>).
54. Samartzis, L., et al. White matter alterations in early stages of schizophrenia: a systematic review of diffusion tensor imaging studies. J. Neuroimaging 24:March–April (2) (2014), 101–110 (ISSN 1552–6569. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/23317110>).
55. Steeds, H., Carhart-Harris, R.L., Stone, J.M., Drug models of schizophrenia. Ther. Adv. Psychopharmacol. 5:February (1) (2015), 43–58 (ISSN 2045. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/25653831>).
56. Steen, R.G., et al. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 188:June (2006), 510–518 (ISSN 0007-1250. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/16738340>).
57. Stuart, M.J., Singhal, G., Baune, B.T., Systematic review of the neurobiological relevance of chemokines to psychiatric disorders. Front. Cell. Neurosci., 9, 2015, 357 (ISSN Available at: < http://www.ncbi.nlm.nih.gov/pubmed/26441528>).
58. Thrall, M.A., Hematologia e bioquímica clínica veterinária. 2007, Roca, São Paulo (592p.).
59. Van Haren, N.E., et al. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol. Psychiatry 63:January (1) (2008), 106–113 (ISSN 1873–2402. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/17599810>).
60. Van OS, J., Kapur, S., Schizophrenia. Lancet 374:August (9690) (2009), 635–645 (ISSN 1474-547X. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/19700006>).
61. Vernon, A.C., et al. Longitudinal in vivo maturational changes of metabolites in the prefrontal cortex of rats exposed to polyinosinic-polycytidylic acid in utero. Eur. Neuropsychopharmacol. 25:December (12) (2015), 2210–2220 (ISSN 1873–7862. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/26475576>).
62. Vorhees, C.V., et al. Prenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine. Neurotoxicol. Teratol. 47:January–February (2015), 54–65 (ISSN 1872–9738. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/25450663>).
63. Vuillermot, S., et al. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J. Neurosci. 30:January (4) (2010), 1270–1287 (ISSN 1529–2401. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/20107055>).
64. Weinberger, D.R., Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44:July (7) (1987), 660–669 (ISSN 0003-990X. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/3606332>).
65. Weinberger, D.R., From neuropathology to neurodevelopment. Lancet 346:August (8974) (1995), 552–557 (ISSN 0140-6736. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/7544856>).
66. Workman, A.D., et al. Modeling transformations of neurodevelopmental sequences across mammalian species. J. Neurosci. 33:April (17) (2013), 7368–7383 (ISSN 1529–2401. Available at: < http://www.ncbi.nlm.nih.gov/pubmed/23616543>).
67. Yee, N., et al. Differential effects of maternal immune activation and juvenile stress on anxiety-like behaviour and physiology in adult rats: no evidence for the double-hit hypothesis. Behav. Brain Res. 224:October (1) (2011), 180–188 (ISSN 1872–7549. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/21679729>).
68. Zavitsanou, K., et al. Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: amelioration by COX-2 inhibition. Brain Behav. Immun. 41:October (2014), 173–181 (ISSN 1090–2139. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/24878170>).
69. Zuckerman, L., Weiner, I., Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J. Psychiatr. Res. 39:May (3) (2005), 311–323 (ISSN 0022-3956. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/15725430>).
70. Zuckerman, L., et al. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28:October (10) (2003), 1778–1789 (ISSN 0893-133X. Available at: < https://www.ncbi.nlm.nih.gov/pubmed/12865897>).